| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Operating Officer
2 companies
Bruno Julianne is a Director at GLTO with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 5 sells.
Estimated insider holdings value: $4.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 21, 2025 | CRSP Crispr Therapeutics AG | Chief Operating Officer | Sale+OE | 1,714 | $41.23 | $70,668.22 | -14.0% | +7.4% | +12.2% | |
| Mar 12, 2025 | CRSP Crispr Therapeutics AG | Chief Operating Officer | Sale+OE | 1,388 | $42.54 | $59,049.96 | -7.6% | -1.3% | +12.4% | |
| Feb 19, 2025 | CRSP Crispr Therapeutics AG | Chief Operating Officer | Sale+OE | 333 | $52.80 | $17,582.40 | -4.5% | -26.0% | +3.1% | |
| Jun 21, 2024 | CRSP Crispr Therapeutics AG | Chief Operating Officer | Sale+OE | 3,366 | $56.09 | $188,798.94 | -33.3% | -12.0% | -21.3% |